MEDP
Medpace Holdings Inc
Medpace Holdings Inc historical holders
total: 8
Pzena Investment Management Medpace Holdings Inc transactions over time
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2022 Q2
- Held for:
- 2 quarters
- Latest activity:
- 2022 Q4
Richard Pzena has been an institutional investor in Medpace Holdings Inc (MEDP) since 2022 Q2. According to 2026 Q2 report, Richard Pzena doesn't hold any shares. The fund/company first acquired MEDP in 2022 Q2, initially purchasing 4,278 shares. Since the initial investment, Pzena Investment Management has made 2 more transactions in this position.
When did Richard Pzena exit their MEDP position?
Richard Pzena no longer holds Medpace Holdings Inc (MEDP). They sold off their entire position in 2022 Q4, closing out an investment that began in 2022 Q2.
When did Richard Pzena first invest in MEDP?
Richard Pzena first invested in Medpace Holdings Inc (MEDP) in 2022 Q2 at the reported quarter-end price of $149.60 per share, acquiring 4,278 shares in their initial purchase.
What is Richard Pzena's average cost basis for MEDP?
Based on historical transaction data, Richard Pzena's estimated cost basis for Medpace Holdings Inc (MEDP) is approximately $149.60 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $149.60
- Weighted AVG sell price:
- $157.11
MEDP transactions history by Pzena Investment Management
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q4
|
0.00%
|
0
|
$157.11
|
|
-100% (-3,870)
|
-0%
|
|
2022 Q3
|
0.00%
|
3,870
|
$157.11
|
$608,000
|
-9.54% (-408)
|
-0%
|
|
2022 Q2
|
0.00%
|
4,278
|
$149.60
|
$640,000
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.